{
  "package" : "hl7.fhir.r4.examples@4.0.1",
  "definition" : null,
  "system" : "http://terminology.hl7.org/CodeSystem/v2-0227",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#status",
    "code" : "status",
    "valueCode" : "deprecated"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#deprecationDate",
    "code" : "deprecationDate",
    "valueDateTime" : "2011-01"
  } ],
  "codesystem" : "7fddfdb0-d755-5056-9246-08b3cafa412e",
  "concept_id" : "e3b7a5ec-dc17-5db3-bdf3-3255ea9d1c8d",
  "ancestors" : {
    "NOV" : 0
  },
  "extension" : [ {
    "url" : "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
    "valueString" : "(includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)",
    "_valueString" : {
      "extension" : [ {
        "url" : "http://hl7.org/fhir/StructureDefinition/translation",
        "extension" : [ {
          "url" : "lang",
          "valueCode" : "nl"
        }, {
          "url" : "content",
          "valueString" : "(inclusief Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines en Evans Limited, Ciba-Geigy Limited en Sandoz Limited)"
        } ]
      } ]
    }
  } ],
  "id" : "e13164d5-b8d7-4596-9e12-863c60f22610",
  "code" : "NOV",
  "display" : "Novartis Pharmaceutical Corporation",
  "designation" : [ {
    "use" : {
      "code" : "display",
      "system" : "http://terminology.hl7.org/CodeSystem/designation-usage"
    },
    "value" : "Novartis Pharmaceutical Corporation",
    "language" : "nl"
  } ],
  "version" : "2.9"
}